Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 2
2023 5
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Bone Quality in Patients with a Congenital Myopathy: A Scoping Review.
Bouman K, Dittrich ATM, Groothuis JT, van Engelen BGM, Janssen MCH, Voermans NC, Draaisma JMT, Erasmus CE. Bouman K, et al. Among authors: dittrich atm. J Neuromuscul Dis. 2023;10(1):1-13. doi: 10.3233/JND-221543. J Neuromuscul Dis. 2023. PMID: 36314217 Free PMC article.
LAMA2-Related Muscular Dystrophy Across the Life Span: A Cross-sectional Study.
Bouman K, Groothuis JT, Doorduin J, van Alfen N, Udink Ten Cate FEA, van den Heuvel FMA, Nijveldt R, Kamsteeg EJ, Dittrich ATM, Draaisma JMT, Janssen MCH, van Engelen BGM, Erasmus CE, Voermans NC. Bouman K, et al. Among authors: dittrich atm. Neurol Genet. 2023 Jul 19;9(5):e200089. doi: 10.1212/NXG.0000000000200089. eCollection 2023 Oct. Neurol Genet. 2023. PMID: 37476021 Free PMC article.
A Retrospective, Nationwide, Multicenter Study on Diagnosis and Treatment Outcome of Pediatric Optic Pathway/Hypothalamic Gliomas Including Analysis of Risk Factors for Progression After Systemic Anticancer Therapy.
Bennebroek CAM, van Zwol J, Montauban van Swijndregt MC, Porro GL, Oostenbrink R, Dittrich ATM, Pott JW, Meijer L, Janssen EJM, Klinkenberg S, Bauer NJ, Notting IC, van Genderen MM, Tanck MW, de Graaf P, Saeed P, Schouten-van Meeteren AYN. Bennebroek CAM, et al. Among authors: dittrich atm. Cancers (Basel). 2025 Feb 20;17(5):716. doi: 10.3390/cancers17050716. Cancers (Basel). 2025. PMID: 40075564 Free PMC article.
Bone quality in LAMA2-related muscular dystrophy and SELENON-related congenital myopathy, a one-year prospective natural history study.
Bouman K, Dittrich ATM, Groothuis JT, van Engelen BGM, Zweers-van Essen H, de Baaij-Daalmeyer A, Janssen MCH, Erasmus CE, Draaisma JMT, Voermans NC. Bouman K, et al. Among authors: dittrich atm. Neuromuscul Disord. 2024 Jan;34:105-113. doi: 10.1016/j.nmd.2023.11.008. Epub 2023 Dec 2. Neuromuscul Disord. 2024. PMID: 38160563 Free article.
Impact of Bevacizumab on Visual Function, Tumor Size, and Toxicity in Pediatric Progressive Optic Pathway Glioma: A Retrospective Nationwide Multicentre Study.
Bennebroek CAM, van Zwol J, Porro GL, Oostenbrink R, Dittrich ATM, Groot ALW, Pott JW, Janssen EJM, Bauer NJ, van Genderen MM, Saeed P, Lequin MH, de Graaf P, Schouten-van Meeteren AYN. Bennebroek CAM, et al. Among authors: dittrich atm. Cancers (Basel). 2022 Dec 10;14(24):6087. doi: 10.3390/cancers14246087. Cancers (Basel). 2022. PMID: 36551572 Free PMC article.
Correction: A 5-year natural history study in LAMA2-related muscular dystrophy and SELENON-related myopathy: the Extended LAST STRONG study.
de Laat ECM, Houwen-van Opstal SLS, Bouman K, van Doorn JLM, Cameron D, van Alfen N, Dittrich ATM, Kamsteeg EJ, Smeets HJM, Groothuis JT, Erasmus CE, Voermans NC. de Laat ECM, et al. Among authors: dittrich atm. BMC Neurol. 2024 Dec 16;24(1):477. doi: 10.1186/s12883-024-03994-5. BMC Neurol. 2024. PMID: 39681838 Free PMC article. No abstract available.
15 results